Role of Noninvasive Fibrosis Methods in Management of Chronic Hepatitis B Virus

[1]  L. Adams,et al.  The ability of Hepascore to predict liver fibrosis in chronic liver disease: a meta‐analysis , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[2]  Xu Li,et al.  Development of algorithms based on serum markers and transient elastography for detecting significant fibrosis and cirrhosis in chronic hepatitis B patients: Significant reduction in liver biopsy , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  Zhiqiao Zhang,et al.  The Diagnostic Accuracy and Clinical Utility of Three Noninvasive Models for Predicting Liver Fibrosis in Patients with HBV Infection , 2016, PloS one.

[4]  Rohit Loomba,et al.  Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. , 2016, Journal of hepatology.

[5]  Q. Lu,et al.  Stiffness Value and Serum Biomarkers in Liver Fibrosis Staging: Study in Large Surgical Specimens in Patients with Chronic Hepatitis B. , 2016, Radiology.

[6]  N. Terrault,et al.  AASLD guidelines for treatment of chronic hepatitis B , 2016, Hepatology.

[7]  Hwa-Koon Wu,et al.  Non-Invasive Evaluation of Hepatic Fibrosis: The Diagnostic Performance of Magnetic Resonance Elastography in Patients with Viral Hepatitis B or C , 2015, PloS one.

[8]  E. Tapper,et al.  Vibration-controlled transient elastography: a practical approach to the noninvasive assessment of liver fibrosis , 2015, Current opinion in gastroenterology.

[9]  M. Ravanelli,et al.  Acoustic radiation force impulse quantification of spleen elasticity for assessing liver fibrosis , 2015, Abdominal Imaging.

[10]  Mohammad Hassan Murad,et al.  Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. , 2015, Clinical Gastroenterology and Hepatology.

[11]  E. Tapper,et al.  Contemporary assessment of hepatic fibrosis. , 2015, Clinics in liver disease.

[12]  R. Thimme,et al.  Natural history of chronic hepatitis B virus infection , 2015, Medical Microbiology and Immunology.

[13]  A. Moorman,et al.  APRI and FIB‐4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS) , 2014, Journal of viral hepatitis.

[14]  J. Boscarino,et al.  The validity of serum markers for fibrosis staging in chronic hepatitis B and C , 2014, Journal of viral hepatitis.

[15]  Julien Vergniol,et al.  Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®. , 2014, Journal of hepatology.

[16]  R. Yantiss,et al.  FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B , 2014, BMC Gastroenterology.

[17]  P. Faure,et al.  Prospective evaluation of FibroTest®, FibroMeter®, and HepaScore® for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C. , 2014, Journal of hepatology.

[18]  R. Pozzi Mucelli,et al.  Noninvasive diagnosis of cirrhosis: a review of different imaging modalities. , 2014, World journal of gastroenterology.

[19]  G. Hauser,et al.  FibroTest/Fibrosure for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis , 2014, The American Journal of Gastroenterology.

[20]  Joon Koo Han,et al.  Noninvasive Assessment of Hepatic Fibrosis in Patients with Chronic Hepatitis B Viral Infection Using Magnetic Resonance Elastography , 2014, Korean journal of radiology.

[21]  Eun Sun Lee,et al.  MR elastography for noninvasive assessment of hepatic fibrosis: Reproducibility of the examination and reproducibility and repeatability of the liver stiffness value measurement , 2014, Journal of magnetic resonance imaging : JMRI.

[22]  N. Afdhal,et al.  Utilization of FibroScan in Clinical Practice , 2014, Current Gastroenterology Reports.

[23]  S. Venkatesh,et al.  Magnetic resonance elastography of liver in healthy asians: Normal liver stiffness quantification and reproducibility assessment , 2014, Journal of magnetic resonance imaging : JMRI.

[24]  A. Ba-Ssalamah,et al.  Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging. , 2013, Radiology.

[25]  F. Sanai,et al.  Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[26]  B. Kiefer,et al.  Susceptibility-weighted MR imaging in the grading of liver fibrosis: a feasibility study. , 2013, Radiology.

[27]  P. Wiggermann,et al.  Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3 Tesla. , 2013, European journal of radiology.

[28]  M. Friedrich-Rust,et al.  The influence of aminotransferase levels on liver stiffness assessed by Acoustic Radiation Force Impulse Elastography: a retrospective multicentre study. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[29]  G. Bedogni,et al.  Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution , 2013, Hepatology.

[30]  Eva Herrmann,et al.  The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis , 2013, European Radiology.

[31]  H. Wang,et al.  Comparison of FIB‐4 and APRI in Chinese HBV‐infected patients with persistently normal ALT and mildly elevated ALT , 2013, Journal of viral hepatitis.

[32]  R. Ehman,et al.  Magnetic resonance elastography of liver: Technique, analysis, and clinical applications , 2013, Journal of magnetic resonance imaging : JMRI.

[33]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[34]  Ioan Sporea,et al.  Acoustic Radiation Force Impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study. , 2012, European journal of radiology.

[35]  V. Wong,et al.  Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease , 2012, The American Journal of Gastroenterology.

[36]  U. Motosugi,et al.  Multi-organ perfusion CT in the abdomen using a 320-detector row CT scanner: preliminary results of perfusion changes in the liver, spleen, and pancreas of cirrhotic patients. , 2012, European journal of radiology.

[37]  Jun Yong Park,et al.  Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis , 2012, PloS one.

[38]  Simona Bota and Ioan Sporea.  Acoustic Radiation Force Impulse Elastography , 2012 .

[39]  Y. Ohno,et al.  CT hepatic perfusion measurement: comparison of three analytic methods. , 2012, European journal of radiology.

[40]  R. Gish,et al.  Chronic Hepatitis B Infection , 2005 .

[41]  Y. N. Park,et al.  Prospective Validation of FibroTest in Comparison with Liver Stiffness for Predicting Liver Fibrosis in Asian Subjects with Chronic Hepatitis B , 2012, PloS one.

[42]  T. Asselah,et al.  Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[43]  I Joubert,et al.  Magnetic resonance elastography: feasibility of liver stiffness measurements in healthy volunteers at 3T. , 2012, Clinical radiology.

[44]  Jill Tinmouth,et al.  Does this patient with liver disease have cirrhosis? , 2012, JAMA.

[45]  M. Lupsor,et al.  Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta‐analysis , 2012, Journal of viral hepatitis.

[46]  M. Attanasio,et al.  Comparison of Transient Elastography and Acoustic Radiation Force Impulse for Non-Invasive Staging of Liver Fibrosis in Patients With Chronic Hepatitis C , 2011, The American Journal of Gastroenterology.

[47]  Jeong Min Lee,et al.  MR elastography for noninvasive assessment of hepatic fibrosis: Experience from a tertiary center in asia , 2011, Journal of magnetic resonance imaging : JMRI.

[48]  Josh Levitsky,et al.  Magnetic Resonance Elastography and Biomarkers to Assess Fibrosis From Recurrent Hepatitis C in Liver Transplant Recipients , 2011, Transplantation.

[49]  D. Gretch,et al.  Use of the AST to platelet ratio index in HCV/HIV co‐infected patients , 2011, Alimentary pharmacology & therapeutics.

[50]  M. Lindstrom,et al.  Effects of postprandial state and mesenteric blood flow on the repeatability of MR elastography in asymptomatic subjects , 2011, Journal of magnetic resonance imaging : JMRI.

[51]  P. Bedossa,et al.  Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). , 2010, Journal of hepatology.

[52]  D. Schuppan,et al.  Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis , 2010, Journal of gastroenterology and hepatology.

[53]  S. Bota,et al.  Spleen assessment by Acoustic Radiation Force Impulse Elastography (ARFI) for prediction of liver cirrhosis and portal hypertension. , 2010, Medical ultrasonography.

[54]  Kunihiro Hosono,et al.  Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. , 2010, Radiology.

[55]  I. Sporea,et al.  Acoustic Radiation Force Impulse Elastography as Compared to Transient Elastography and Liver Biopsy in Patients with Chronic Hepatopathies , 2010, Ultraschall in der Medizin.

[56]  Wenping Wang,et al.  Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography. , 2010, Ultrasound in medicine & biology.

[57]  G. Baron,et al.  Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT. , 2010, Radiology.

[58]  Y. Paik,et al.  Validation of FIB‐4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus‐infected patients , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[59]  Gabriela Marinoschi,et al.  Acoustic radiation force imaging sonoelastography for noninvasive staging of liver fibrosis. , 2009, World journal of gastroenterology.

[60]  Radu Badea,et al.  Performance of a new elastographic method (ARFI technology) compared to unidimensional transient elastography in the noninvasive assessment of chronic hepatitis C. Preliminary results. , 2009, Journal of gastrointestinal and liver diseases : JGLD.

[61]  R. Sinkus,et al.  Magnetic resonance elastography in the liver at 3 Tesla using a second harmonic approach , 2009, Magnetic resonance in medicine.

[62]  Eva Herrmann,et al.  Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. , 2009, Radiology.

[63]  N. Afdhal,et al.  Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[64]  Pierre Bedossa,et al.  Non‐invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[65]  A. Chan,et al.  Alanine aminotransferase‐based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B , 2009, Journal of viral hepatitis.

[66]  S. Varnous,et al.  Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency , 2008, Hepatology.

[67]  Fabrice Charleux,et al.  Measurement of liver stiffness with two imaging techniques: Magnetic resonance elastography and ultrasound elastometry , 2008, Journal of magnetic resonance imaging : JMRI.

[68]  R. Levine,et al.  Diagnostic Accuracy of Serum Hyaluronic Acid, FIBROSpect II, and YKL-40 for Discriminating Fibrosis Stages in Chronic Hepatitis C , 2008, The American Journal of Gastroenterology.

[69]  Benjamin J. Hyatt,et al.  The clinical significance of persistently normal ALT in chronic hepatitis B infection. , 2007, Journal of hepatology.

[70]  I. Guha,et al.  Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers , 2007, Hepatology.

[71]  Patrice Cacoub,et al.  Meta-analyses of FibroTest diagnostic value in chronic liver disease , 2007, BMC gastroenterology.

[72]  A. Manduca,et al.  Assessment of hepatic fibrosis with magnetic resonance elastography. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[73]  J. P. Sampaio,et al.  Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection , 2007, Hepatology.

[74]  E. Schiff,et al.  Prospective Evaluation of FIBROSpect II for Fibrosis Detection in Hepatitis C and B Patients Undergoing Laparoscopic Biopsy. , 2007, Gastroenterology & hepatology.

[75]  Richard L Ehman,et al.  MR elastography of the liver: preliminary results. , 2006, Radiology.

[76]  D. Weiss,et al.  Aspartate Aminotransferase to Platelet Ratio Index in Patients with Alcoholic Liver Fibrosis , 2006, The American Journal of Gastroenterology.

[77]  Albert Tran,et al.  Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest–Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study , 2006, The American Journal of Gastroenterology.

[78]  A. Lok,et al.  Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005 , 2006, Hepatology.

[79]  J. Kench,et al.  Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. , 2005, Clinical chemistry.

[80]  R. Stauber,et al.  Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C , 2005, Hepatology.

[81]  V. de Lédinghen,et al.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. , 2005, Gastroenterology.

[82]  D. Schuppan,et al.  Serum markers detect the presence of liver fibrosis: a cohort study. , 2004, Gastroenterology.

[83]  D. Thabut,et al.  Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C , 2004, Comparative hepatology.

[84]  S. Massarrat,et al.  Clinical, biochemical and imaging‐verified regression of hepatitis B‐induced cirrhosis , 2004, Liver international : official journal of the International Association for the Study of the Liver.

[85]  D. Ganem,et al.  Hepatitis B virus infection--natural history and clinical consequences. , 2004, The New England journal of medicine.

[86]  F. Morel,et al.  Circulating Matrix Metalloproteinases 1, 2, 9 and Their Inhibitors TIMP-1 and TIMP-2 as Serum Markers of Liver Fibrosis in Patients With Chronic Hepatitis C: Comparison With PIIINP and Hyaluronic Acid , 2004, American Journal of Gastroenterology.

[87]  M. Ziol,et al.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. , 2003, Ultrasound in medicine & biology.

[88]  J. Kalbfleisch,et al.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.

[89]  G. Fattovich.  Natural History and Prognosis of Hepatitis B , 2003, Seminars in liver disease.

[90]  R. Testa,et al.  Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. , 2003, Archives of internal medicine.

[91]  O. Cummings,et al.  Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C , 2000, American Journal of Gastroenterology.

[92]  O. Cummings,et al.  Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C. , 2000 .

[93]  M. Bachem,et al.  α2‐Macroglobulin reduces paracrine‐ and autocrine‐stimulated matrix synthesis of cultured rat hepatic stellate cells , 1999 .

[94]  P. Timms,et al.  Plasma Levels of Matrix Metalloproteinase-2 (MMP-2) and Tissue Inhibitors of Metalloproteinases-1 and -2 (TIMP-1 and TIMP-2) as Noninvasive Markers of Liver Disease in Chronic Hepatitis C Comparison Using ROC Analysis , 1999, Digestive Diseases and Sciences.

[95]  F. Gordon,et al.  AST/ALT Ratio Predicts Cirrhosis in Patients With Chronic Hepatitis C Virus Infection , 1998, American Journal of Gastroenterology.

[96]  A. Manduca,et al.  Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. , 1995, Science.

[97]  박준용,et al.  Factors Influencing the Diagnostic Accuracy of Acoustic Radiation Force Impulse Elastography in Patients with Chronic Hepatitis B , 2016 .

[98]  E. Tapper,et al.  FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[99]  P. Crotty,et al.  Feasibility and reliability of the FibroScan S2 (pediatric) probe compared with the M probe for liver stiffness measurement in small adults with chronic liver disease. , 2013, Annals of hepatology.

[100]  S. Venkatesh,et al.  Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B , 2013, European Radiology.

[101]  P. Lundberg,et al.  Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA , 2012, European Radiology.

[102]  박준용,et al.  Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients , 2010 .

[103]  T. Poynard,et al.  Biochemical Markers of Fibrosis in Patients with Chronic Hepatitis C: A Comparison with Prothrombin Time, Platelet Count, and Age–Platelet Index , 2004, Digestive Diseases and Sciences.

[104]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[105]  M. Bachem,et al.  Alpha2-macroglobulin reduces paracrine- and autocrine-stimulated matrix synthesis of cultured rat hepatic stellate cells. , 1999, European journal of clinical investigation.